A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

Clinical trial NCT04042558 · COMPLETED

Trial details

NCT number: NCT04042558
Sponsor: Centre Francois Baclesse
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Stage IIIB NSCLC Stage IV EGFR Gene Mutation ALK Gene Rearrangement Positive ROS1 Gene Mutation

Start date: 2019-09-26
Primary completion: 2021-10-22
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.